18 June 2025 - PHARMAC has declined 48 inactive funding applications so that it is clearer what medicines are currently being considered for funding.
Director of Pharmaceuticals, Geraldine MacGibbon, says closing these applications is an important part of making sure PHARMAC’s work is transparent and easy to understand.